Risk management is a key aspect of pharmacovigilance, aiming to minimize harm and maximize the benefits of medications. Once safety concerns are identified and evaluated, appropriate risk management strategies need to be developed and implemented. These strategies may include labeling changes, contraindications, warnings, restrictions on use, or even product withdrawal. Effective communication and dissemination of risk information to healthcare professionals, patients, and regulatory authorities are vital to ensure informed decision-making and promote patient safety. Continuous monitoring and evaluation of the Pharmacovigilance system itself is essential for maintaining its effectiveness. Regular internal audits and inspections help identify areas for improvement and ensure compliance with regulatory requirements.